0001415889-22-012561.txt : 20221214 0001415889-22-012561.hdr.sgml : 20221214 20221214183301 ACCESSION NUMBER: 0001415889-22-012561 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221212 FILED AS OF DATE: 20221214 DATE AS OF CHANGE: 20221214 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Duncan Gregory Scott CENTRAL INDEX KEY: 0001831127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39811 FILM NUMBER: 221463274 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Virios Therapeutics, Inc. CENTRAL INDEX KEY: 0001818844 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 854314201 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 BUSINESS PHONE: 8666208655 MAIL ADDRESS: STREET 1: 44 MILTON AVENUE CITY: ALPHARETTA STATE: GA ZIP: 30009 FORMER COMPANY: FORMER CONFORMED NAME: Virios Therapeutics, LLC DATE OF NAME CHANGE: 20200721 4 1 form4-12142022_111237.xml X0306 4 2022-12-12 0001818844 Virios Therapeutics, Inc. VIRI 0001831127 Duncan Gregory Scott C/O VIRIOS THERAPEUTICS, INC. 44 MILTON AVENUE ALPHARETTA GA 30009 true true false false CHIEF EXECUTIVE OFFICER Stock Option (right to buy) 0.2789 2022-12-12 4 A 0 480000 0 A 2032-12-12 Common Stock 480000 480000 D The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter. /s/ Greg Duncan 2022-12-14